Simon-Kucher & Partners, Cambridge, Massachusetts 02141, USA.
J Pain. 2010 Nov;11(11):1095-108. doi: 10.1016/j.jpain.2010.02.007. Epub 2010 May 10.
This study examined the relative impact of pain relief and opioid side effects on patients' and physicians' preferences for medication. An Internet survey was completed by 618 patients (302 acute pain, 316 chronic pain) and 325 physicians (83 primary care, 80 pain specialists, 41 oncologists, 40 general surgeons, 40 orthopedic surgeons, 20 rheumatologists, 21 neurologists). Respondents completed an Adaptive Conjoint Analysis (ACA) exercise in which they indicated their relative preference for 20 pairs of hypothetical opioid pain medications described by varying levels of pain relief and side-effect incidence. Almost all patients (96% of chronic, 92% of acute) reported experiencing at least 1 side effect while on opioid medication, but physician-estimated incidence rates of most opioid side effects were much lower than those reported by patients. Opioid side effects, rather than pain relief, explained the majority of variance for medication preference for both patients (74% for chronic, 73% for acute) and treating physicians (73% for chronic, 74% for acute) in this exercise. Nausea and vomiting were major determinants of opioid medication preference, with each explaining as much of the variance in preference as did pain relief (21% to 25%). Nausea and vomiting were the most important side effects based on the amount of pain relief that respondents were willing to give up for reducing the incidence of side effects. The importance of side effects was confirmed in an open-ended question where 51% of patients and 58% of physicians identified side-effect reduction as an unmet need for pain medications.
This study provided insights into patient and physician preferences of the risk and benefit balance of opioid therapy. This information could improve understanding of patient needs and facilitate the incorporation of patient preference into therapy choice.
本研究考察了疼痛缓解和阿片类药物副作用对患者和医生对药物选择的偏好的相对影响。通过互联网调查,共完成了 618 名患者(302 名急性疼痛患者,316 名慢性疼痛患者)和 325 名医生(83 名初级保健医生,80 名疼痛专家,41 名肿瘤学家,40 名普通外科医生,40 名骨科医生,20 名风湿病学家,21 名神经科医生)的调查。受访者完成了一项自适应联合分析(ACA)练习,在该练习中,他们根据疼痛缓解和副作用发生率的不同水平,对 20 对假设的阿片类药物疼痛药物的相对偏好进行了评估。几乎所有患者(慢性疼痛患者的 96%,急性疼痛患者的 92%)在服用阿片类药物时至少报告了 1 种副作用,但医生估计大多数阿片类药物副作用的发生率远低于患者报告的发生率。在这项研究中,阿片类药物副作用而不是疼痛缓解解释了患者(慢性疼痛患者的 74%,急性疼痛患者的 73%)和治疗医生(慢性疼痛患者的 73%,急性疼痛患者的 74%)对药物选择的大部分偏好差异。恶心和呕吐是阿片类药物药物选择的主要决定因素,两者对偏好的解释程度与疼痛缓解相当(21%至 25%)。在愿意为降低副作用发生率而放弃的疼痛缓解程度方面,恶心和呕吐是最重要的副作用。在一项开放性问题中,51%的患者和 58%的医生认为减少副作用是疼痛药物的未满足需求,这证实了副作用的重要性。
本研究提供了对患者和医生对阿片类药物治疗风险和益处平衡的偏好的深入了解。这些信息可以提高对患者需求的认识,并促进将患者的偏好纳入治疗选择。